Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 2 Week Study of Topical KD7040 in the Treatment of Postherpetic Neuralgia (PHN)

NCT00576108 is registered in ClinicalTrials.gov with Kalypsys, Inc. as lead sponsor.

NCT NCT00576108
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00576108 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 2 Week Study of Topical KD7040 in the Treatment of Postherpetic Neuralgia (PHN)
Lead sponsor
Kalypsys, Inc.
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2007
Completion date
July 31, 2008
Enrollment
48 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

herpes zoster, neuropathic pain, postherpetic neuralgia, shingles